The short answer
Menopausal hormone therapy is the most effective treatment for hot flashes and night sweats and is generally appropriate for healthy women under 60 or within 10 years of menopause. Service history does not rule it out. A licensed clinician reviews clot, cancer, heart and liver history plus current medicines before deciding. Transdermal estradiol is often preferred, and women with a uterus need progesterone too.
No advertising or analytics trackers run on Specialized Care pages. Reading them is never linked to your identity. Our privacy pledge
Who hormone therapy may suit
For most healthy women under 60 or within 10 years of their last period, benefits for bothersome symptoms usually outweigh risks. Women whose periods stopped before 45, including after surgery, are often advised to take hormones until about the average age of menopause to protect bone and heart health.
When clinicians are more cautious
- Past breast or endometrial cancer
- Past blood clot, stroke or heart attack
- Active liver disease
- Unexplained vaginal bleeding, which needs evaluation first
- Starting more than 10 years after menopause or after age 60
Forms of hormone therapy
| Type | Examples | Notes |
|---|---|---|
| Transdermal estradiol | Patch, gel, spray | Often preferred with clot, migraine or blood pressure concerns |
| Oral estradiol | Tablets | Simple, but slightly higher clot risk |
| Progesterone | Micronized progesterone, IUD | Needed with a uterus; oral progesterone can help sleep |
| Vaginal estrogen | Cream, tablet, ring | For dryness and urinary symptoms; very low absorption |
| Testosterone | Off-label low dose | Sometimes considered for low desire after evaluation |
Medicines common in veterans
- SSRIs and SNRIs for PTSD or depression can also reduce hot flashes, and some doses may change
- Prazosin for nightmares can lower blood pressure
- Some seizure medicines and the antibiotic rifampin can lower hormone levels
- Pain medicines, sleep aids and supplements should all be on your list
How starting works at Kindr
A licensed clinician reviews your history, symptoms and medicines. No medicine, including estrogen, progesterone or testosterone, is promised before that evaluation. If hormone therapy fits, you usually start low and review after about three months.
Keep the care you already have
Kindr does not have to replace your existing care. If you use VA, TRICARE, an employer plan or another provider, you can keep those relationships while Kindr focuses on menopause. Bring your medicine list, including anything VA-prescribed, so nothing is duplicated or conflicts.
Independent from the VA and DoD
Kindr Health is an independent healthcare company and is not affiliated with, endorsed by, or operated by the U.S. Department of Veterans Affairs or Department of Defense. VA and military health care benefits vary by individual. VA benefits do not pay for Kindr visits.
Specialized care pathway
Care that takes your history into account
A private preparation tool builds a summary for a licensed Kindr clinician. Your answers stay in your browser and are not saved or sent.
Questions, answered
Common questions
Is HRT safe for women veterans?
+
For many healthy women under 60, yes. Service history alone is not a reason to avoid it. Clot, cancer and heart history matter most.
Can I take HRT with PTSD medicines?
+
Usually. SSRIs, SNRIs and prazosin can generally be used with hormone therapy, but your clinician checks doses and blood pressure.
Can I switch from VA-prescribed HRT?
+
You can keep VA prescriptions or discuss changes with a Kindr clinician. Avoid taking two hormone prescriptions at once.
WRITTEN & MEDICALLY REVIEWED BY
Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team, led by Kevin Wolfe, CMO
Kindr’s clinical content is written and reviewed by board-certified clinicians who prescribe hormone therapy every day across all 50 states — menopause-focused physicians, nurse practitioners, and pharmacists working under Kindr Health, Inc.’s organizational clinical oversight. Every page is checked against current NAMS and ACOG guidance, FDA labeling, and the primary literature before publication, then re-reviewed on a rolling schedule when guidance changes.
Organizational NPI 1609792902 · Last reviewed October 5, 2026 · Editorial policy
Educational content only — not a substitute for individual medical advice, diagnosis, or treatment.
SOURCES & REFERENCES
Every clinical claim on this page is sourced.
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society (2022) — The Menopause Society. www.menopause.org/docs/default-source/professional/nams-2022-hormone-therapy-position-statement.pdf
- VA/DoD Clinical Practice Guideline for the Management of Menopause (2026) — U.S. Department of Veterans Affairs and Department of Defense. www.healthquality.va.gov
- Menopausal hormone therapy use among active duty service women (2024) — Menopause. pmc.ncbi.nlm.nih.gov/articles/PMC12147746
- Menopause — VA Women's Health. www.womenshealth.va.gov